Mid Cap Unusal Volume: First Citizens BancShares (NASDAQ:FCNCA), Houghton Mifflin Harcourt (NASDAQ:HMHC), Washington Federal (NASDAQ:WAFD), PTC (NASDAQ:PTC), Harsco (NYSE:HSC)

The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of First Citizens Bancorporation, Inc (OTCMKTS:FCBN) shares, was launched concerning whether the takeover of First Citizens Bancorporation, Inc by First Citizens BancShares (NASDAQ:FCNCA), Inc is unfair to First Citizens Bancorporation stockholders. First Citizens BancShares Inc. (NASDAQ:FCNCA) stock performance was -0.62% in last session and finished the day at $247.65. Traded … Continue reading Mid Cap Unusal Volume: First Citizens BancShares (NASDAQ:FCNCA), Houghton Mifflin Harcourt (NASDAQ:HMHC), Washington Federal (NASDAQ:WAFD), PTC (NASDAQ:PTC), Harsco (NYSE:HSC)

Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at $27.81. Traded volume was 4,554,523 shares in the last session … Continue reading Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)